India May Scrap Curbs on Chinese Firms for Govt Contracts
India plans to remove restrictions blocking Chinese companies from bidding on massive government contracts worth up to $750 billion, reports indicate. Read the full analysis.
India plans to remove restrictions blocking Chinese companies from bidding on massive government contracts worth up to $750 billion, reports indicate. Read the full analysis.
Despite aggressive AI adoption, major IT firms show stagnant revenue per employee. Audited metrics reveal the real impact is yet to materialise. Read the full analysis.
India's amended pharma guidelines allow firms to settle minor violations via fines, avoiding court. The move aims to ease regulatory burden under the Drugs and Cosmetics Act. Read the full details.
The combined market valuation of seven of India's top-10 most valued firms jumped by Rs 1,23,290.77 crore last week, with Reliance Industries emerging as the biggest gainer. Discover which stocks drove the rally.
A new report predicts AI will unlock new investment avenues by 2026, with smaller companies poised to gain the most. Discover the key trends shaping India's financial future.
The US Treasury Department imposes new sanctions on Venezuelan oil firms, targeting foreign support for Maduro's government. Read the full analysis of the escalating economic pressure.
Top Indian law firms are moving beyond AI pilots to redesign core legal workflows in 2026 for speed and accuracy, while navigating billing shifts and Supreme Court scrutiny. Explore the transformation.
Discover the leading mobile app development companies in the UK, as referenced by CTOs and product leaders. Find your ideal tech partner for innovative digital solutions.
Karnataka High Court rules embedded power generation companies must comply with state directives during electricity crises. The verdict upholds government orders under Section 11 of the Electricity Act. Read the full details.
Thane police register a case against four individuals for allegedly creating eight fake GST firms and fraudulently claiming over Rs 22 crore in input tax credit. No arrests made yet. Details inside.
Six of India's top 10 most valued firms added Rs 75,257 crore in market capitalisation last week. TCS and Infosys were the biggest gainers, while Reliance Industries saw a decline. Discover the key drivers and stock market trends.
The Deputy Registrar in Lucknow cancels Celebrity Green RWA's registration for serious violations of the UP Apartment Act, 2010. Read the full details of the order and its implications for residents.
US President Donald Trump secures agreements with nine major pharmaceutical companies to reduce Medicaid and cash-pay drug prices, aiming to align US costs with other wealthy nations. Details inside.
Odisha CM Mohan Majhi positions state as top pharma & medical devices investment destination. New policy & parks attract Rs 7,043 crore proposals, 45 MoUs signed. Read more.
Haryana's Hisar district administration cracks down on 20 agricultural input firms for alleged malpractices. Firms must respond within 15 days or face license cancellation.
Five of India's top 10 valued firms added Rs 72,285 crore in market cap last week. TCS and Infosys were the biggest gainers, while Reliance Industries saw a major drop. Discover the full market analysis.
Bangalore Development Authority plans to empanel law firms to handle over 3,500 pending cases delaying key projects. New initiative aims to expedite legal processes.
India's pharmaceutical industry is transitioning toward innovative drugs, with multiple companies preparing obesity reduction launches. Discover how PHARMEXCIL is driving this competitive transformation.
Sudeep Pharma's ₹895 crore IPO witnessed massive demand, subscribed 94 times. QIB portion booked 213x. Shares may list at a 14% premium. Key details inside.
Indian government considers global tenders for patented weight-loss, cancer, and diabetes drugs to ensure patient access. Learn how this move benefits healthcare.
Indian-American billionaire Vivek Ramaswamy's fortune surges to $1.8B despite political setbacks. Discover how his pharma investments fueled this remarkable growth and his Ohio governor campaign.
Seven of India's top 10 companies saw massive market cap surge of Rs 1.28 lakh crore last week. Reliance Industries and Bharti Airtel emerged as biggest gainers in stellar market performance.
Aurobindo Pharma's China facility currently faces $1M loss but aims for break-even by Q3-Q4 FY26. CFO outlines growth drivers including Pen-G ramp-up and biosimilar commercialization.
Karnataka Health Minister Dinesh Gundu Rao urges the pharma sector to adhere to regulations, highlighting critical public health and industry credibility issues.
India-US trade deal negotiations advance with $500 billion bilateral trade target by 2030. Experts reveal which Indian stocks could benefit most from tariff easing.
Eli Lilly makes pharmaceutical history as first company to achieve $1 trillion market capitalization after shares rose 1.7% on November 21, 2025. Learn what this means for investors.
A smallcap pharma stock listed on NSE defied market trends with a 10% surge on November 21, 2024. Discover the driving factors behind this remarkable performance.
Balaxi Pharmaceuticals shares surged 10% to ₹39.5 in intraday trade Friday, defying market weakness. However, the stock remains down 47.42% YTD with retail investors facing significant wealth erosion.
Tragic boiler explosion at pharmaceutical factory in Pakistan's Punjab province claims 15 lives, leaves dozens injured. Emergency response underway.
OPPI Annual Summit 2025 highlights strategic partnerships accelerating India's pharmaceutical transformation. Discover key insights from industry leaders.